What's new

Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 23, Status: Authorised

Mar 7, 2025 - 15:49
 0
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Holoclar, ex vivo expa...

Next Article

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib...

Related Posts

PSUSA/00000342/202407

PSUSA/00000342/202407

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Aripiprazole Accord, aripiprazole, Date of authorisation: 15/11/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and varicella vaccine (live), Date of authorisation: 05/04/2006, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0